TY - JOUR
T1 - Identification of microduplications at Xp21.2 and Xq13.1 in neurodevelopmental disorders
AU - Kokkonen, Hannaleena
AU - Siren, Auli
AU - Määttä, Tuomo
AU - Kamila Kadlubowska, Magda
AU - Acharya, Anushree
AU - Nouel-Saied, Liz M.
AU - Leal, Suzanne M.
AU - Järvelä, Irma
AU - Schrauwen, Isabelle
N1 - Funding Information:
We thank the patients and their families for their participation in this study. We are grateful for Anju K Philips and Shaffaq Raza for excellent technical help and Dr. Bernardini (IRCCS CSS‐Mendel Institute, Italy), Dr. Tzschach (University Medical Center Freiburg, Germany), and Dr. McGowan (West of Scotland Centre for Genomic Medicine, UK) for contributing their DECIPHER data. This study makes use of data generated by the DECIPHER community. A full list of contributing centers is available from https://decipher.sanger.ac.uk/about/stats and via email ( [email protected] ). Funding for the DECIPHER project was provided by Wellcome. DECIPHER contributing scientists bear no responsibility for the further analysis or interpretation of the data presented here.
Publisher Copyright:
© 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
PY - 2021/5/12
Y1 - 2021/5/12
N2 - Background: Microduplications are a rare cause of disease in X-linked neurodevelopmental disorders but likely have been under reported due challenges in detection and interpretation. Methods: We performed exome sequencing and subsequent microarray analysis in two families with a neurodevelopmental disorder. Results: Here, we report on two families each with unique inherited microduplications at Xp21.2 and Xq13.1, respectively. In the first family, a 562.8-kb duplication at Xq13.1 covering DLG3, TEX11, SLC7A3, GDPD2, and part KIF4A was identified in a boy whose phenotype was characterized by delayed speech development, mild intellectual disability (ID), mild dysmorphic facial features, a heart defect, and neuropsychiatric symptoms. By interrogating all reported Xq13.1 duplications in individuals affected with a neurodevelopmental disorder, we provide evidence that this genomic region and particularly DLG3 might be sensitive to an increased dosage. In the second family with four affected males, we found a noncontinuous 223- and 204-kb duplication at Xp21.2, of which the first duplication covers exon 6 of IL1RAPL1. The phenotype of the male patients was characterized by delayed speech development, mild to moderate ID, strabismus, and neurobehavioral symptoms. The carrier daughter and her mother had learning difficulties. IL1RAPL1 shows nonrecurrent causal structural variation and is located at a common fragile site (FRAXC), prone to re-arrangement. Conclusion: In conclusion, we show that comprehensive clinical and genetic examination of microduplications on the X-chromosome can be helpful in undiagnosed cases of neurodevelopmental disease.
AB - Background: Microduplications are a rare cause of disease in X-linked neurodevelopmental disorders but likely have been under reported due challenges in detection and interpretation. Methods: We performed exome sequencing and subsequent microarray analysis in two families with a neurodevelopmental disorder. Results: Here, we report on two families each with unique inherited microduplications at Xp21.2 and Xq13.1, respectively. In the first family, a 562.8-kb duplication at Xq13.1 covering DLG3, TEX11, SLC7A3, GDPD2, and part KIF4A was identified in a boy whose phenotype was characterized by delayed speech development, mild intellectual disability (ID), mild dysmorphic facial features, a heart defect, and neuropsychiatric symptoms. By interrogating all reported Xq13.1 duplications in individuals affected with a neurodevelopmental disorder, we provide evidence that this genomic region and particularly DLG3 might be sensitive to an increased dosage. In the second family with four affected males, we found a noncontinuous 223- and 204-kb duplication at Xp21.2, of which the first duplication covers exon 6 of IL1RAPL1. The phenotype of the male patients was characterized by delayed speech development, mild to moderate ID, strabismus, and neurobehavioral symptoms. The carrier daughter and her mother had learning difficulties. IL1RAPL1 shows nonrecurrent causal structural variation and is located at a common fragile site (FRAXC), prone to re-arrangement. Conclusion: In conclusion, we show that comprehensive clinical and genetic examination of microduplications on the X-chromosome can be helpful in undiagnosed cases of neurodevelopmental disease.
KW - exome sequencing
KW - intellectual disability
KW - microduplication
KW - neurodevelopmental disorders
KW - X-chromosome
U2 - 10.1002/mgg3.1703
DO - 10.1002/mgg3.1703
M3 - Article
AN - SCOPUS:85105639471
SN - 2324-9269
JO - Molecular Genetics and Genomic Medicine
JF - Molecular Genetics and Genomic Medicine
ER -